Roberta Caputo

2.0k total citations
27 papers, 1.4k citations indexed

About

Roberta Caputo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Roberta Caputo has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Roberta Caputo's work include HER2/EGFR in Cancer Research (10 papers), Breast Cancer Treatment Studies (9 papers) and Advanced Breast Cancer Therapies (7 papers). Roberta Caputo is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Breast Cancer Treatment Studies (9 papers) and Advanced Breast Cancer Therapies (7 papers). Roberta Caputo collaborates with scholars based in Italy, France and United States. Roberta Caputo's co-authors include Vincenzo Damiano, Giampaolo Tortora, Fortunato Ciardiello, Rosa Caputo, Teresa Troiani, A R Bianco, Bianca Maria Veneziani, Roberto Bianco, Michelino De Laurentiis and Michela Piezzo and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Roberta Caputo

23 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta Caputo Italy	13	805	664	612	317	95	27	1.4k
Chiara Lazzari Italy	24	883 1.1×	738 1.1×	580 0.9×	313 1.0×	74 0.8×	67	1.5k
Zhenfan Yang China	19	1.1k 1.3×	1.2k 1.8×	549 0.9×	308 1.0×	91 1.0×	39	1.8k
Marianna Gallo Italy	18	693 0.9×	328 0.5×	588 1.0×	319 1.0×	115 1.2×	37	1.3k
Toshimitsu Uenaka Japan	18	652 0.8×	509 0.8×	797 1.3×	258 0.8×	92 1.0×	33	1.8k
Alexios Matikas Sweden	19	929 1.2×	370 0.6×	395 0.6×	413 1.3×	69 0.7×	92	1.4k
Cataldo Bianco Italy	24	765 1.0×	427 0.6×	757 1.2×	252 0.8×	169 1.8×	37	1.5k
Dana T. Aftab United States	20	882 1.1×	574 0.9×	803 1.3×	417 1.3×	112 1.2×	45	1.8k
Gareth Hughes United Kingdom	13	627 0.8×	321 0.5×	694 1.1×	266 0.8×	76 0.8×	22	1.3k
Victoria L. Chiou United States	9	875 1.1×	375 0.6×	617 1.0×	225 0.7×	137 1.4×	24	1.6k
Siyuan Weng China	18	523 0.6×	530 0.8×	717 1.2×	442 1.4×	138 1.5×	75	1.5k

Countries citing papers authored by Roberta Caputo

Since Specialization

Citations

This map shows the geographic impact of Roberta Caputo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Caputo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Caputo more than expected).

Fields of papers citing papers by Roberta Caputo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Caputo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Caputo. The network helps show where Roberta Caputo may publish in the future.

Co-authorship network of co-authors of Roberta Caputo

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Caputo. A scholar is included among the top collaborators of Roberta Caputo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Caputo. Roberta Caputo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arecco, Luca, Eva Blondeaux, Marco Bruzzone, et al.. (2025). Prognostic implications of risk definitions from the monarchE and NATALEE trials. JNCI Journal of the National Cancer Institute. 117(6). 1198–1208. 3 indexed citations

Laurentiis, Michelino De, et al.. (2025). In Defense of Adjuvant CDK4/6 Inhibitors in Early Breast Cancer. Journal of Clinical Oncology. 43(35). 3691–3697.

Botticelli, Andrea, Alessandra Fabi, Alessandro Rossi, et al.. (2024). Trastuzumab deruxtecan in patients with breast cancer with brain metastases: The DE-REAL study.. Journal of Clinical Oncology. 42(16_suppl). 1032–1032. 1 indexed citations

Buono, Giuseppe, Monica Capozzi, Roberta Caputo, et al.. (2024). CAR-T cell therapy for breast cancer: Current status and future perspective. Cancer Treatment Reviews. 133. 102868–102868. 7 indexed citations

Caputo, Roberta, Giuseppe Buono, Michela Piezzo, et al.. (2024). Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis. Frontiers in Oncology. 14. 1362641–1362641. 29 indexed citations

Caputo, Roberta, et al.. (2023). Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report. Frontiers in Oncology. 13. 1214660–1214660.

Munzone, Elisabetta, Alessandra Fabi, Giuseppe Buono, et al.. (2023). The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients. Drugs & Therapy Perspectives. 39(12). 432–446.

Cocco, Stefania, Alessandra Leone, Maria Serena Roca, et al.. (2022). Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models. Journal of Translational Medicine. 20(1). 290–290. 79 indexed citations

Caputo, Roberta, Alessandra Fabi, Emanuela Romagnoli, et al.. (2022). Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial. Breast Cancer Targets and Therapy. Volume 14. 351–362.

10.

Caputo, Roberta, Marina Elena Cazzaniga, Andrea Sbrana, et al.. (2020). Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study. BMC Cancer. 20(1). 232–232. 7 indexed citations

11.

Piezzo, Michela, Stefania Cocco, Roberta Caputo, et al.. (2020). Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors. International Journal of Molecular Sciences. 21(18). 6479–6479. 126 indexed citations

12.

Cocco, Stefania, Alessandra Leone, Michela Piezzo, et al.. (2020). Targeting Autophagy in Breast Cancer. International Journal of Molecular Sciences. 21(21). 7836–7836. 73 indexed citations

13.

Piezzo, Michela, Paolo Chiodini, Stefania Cocco, et al.. (2020). Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 21(17). 6400–6400. 79 indexed citations

14.

Conforti, Alessandro, Francesco Schettini, Roberta Vallone, et al.. (2019). Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues. The Breast Journal. 25(6). 1310–1311. 5 indexed citations

15.

Fabi, Alessandra, Lucia Del Mastro, Katia Cannita, et al.. (2019). Long-term toxicity profile of trastuzumab emtansine (T-DM1): A multicenter real-life study.. Journal of Clinical Oncology. 37(15_suppl). e12507–e12507. 5 indexed citations

16.

Caputo, Roberta, Daniela Cianniello, Michela Piezzo, et al.. (2019). Gene Expression Assay in the Management of Early Breast Cancer. Current Medicinal Chemistry. 27(17). 2826–2839. 9 indexed citations

17.

Placido, Sabino De, Mario Giuliano, Francesco Schettini, et al.. (2018). Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results. The Breast. 38. 86–91. 20 indexed citations

18.

Bianco, Roberto, Roberta Caputo, Rosa Caputo, et al.. (2004). Combined Targeting of Epidermal Growth Factor Receptor and MDM2 by Gefitinib and Antisense MDM2 Cooperatively Inhibit Hormone-Independent Prostate Cancer. Clinical Cancer Research. 10(14). 4858–4864. 40 indexed citations

19.

Tortora, Giampaolo, Rosa Caputo, Vincenzo Damiano, et al.. (2003). Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity.. PubMed. 9(2). 866–71. 45 indexed citations

20.

Bianco, Cataldo, Giampaolo Tortora, Roberto Bianco, et al.. (2002). Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).. PubMed. 8(10). 3250–8. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact